SOLID DISPERSION COMPRISING 20-O-β-D-GLUCOPYRANOSYL-20(S)-PROTOPANAXADIOL

PURPOSE: A solid dispersion containing 20-O-beta-D-glucopyranosyl-20(S)-protopanaxadiol and saturated polyglycolated glyceride is provided. CONSTITUTION: A solid dispersion contains 20-O-beta-D-glucopyranosyl-20(S)-protopanaxadio as a pharmacologically active ingredient and saturated polyglycosylate...

Full description

Saved in:
Bibliographic Details
Main Authors JANG, JAE WON, LEE, SUNG KYUN, PARK, YONG DUCK, CHI, SANG CHEOL, HUR, BONG HANG
Format Patent
LanguageEnglish
Korean
Published 15.06.2011
Subjects
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
Online AccessGet full text

Cover

More Information
Summary:PURPOSE: A solid dispersion containing 20-O-beta-D-glucopyranosyl-20(S)-protopanaxadiol and saturated polyglycolated glyceride is provided. CONSTITUTION: A solid dispersion contains 20-O-beta-D-glucopyranosyl-20(S)-protopanaxadio as a pharmacologically active ingredient and saturated polyglycosylated glyceride as a lipid matrix. The saturated polyglycolated glyceride is a mixture of mono-, di- and tri-glyceride and polyethylene glyceride and mono- and di-ester of polyethylene glycol. The solid dispersion is a capsule. A pharmaceutical formulation contains the solid dispersion and pharmaceutically acceptable additive. The formulation is a capsule or table.
Bibliography:Application Number: KR20090121077